|
|
||
Immunogenic sites on anti-TNF drugsHuman mAb (adalimumab) |
||
![]() |
||
|
C1:
Allotypic epitopes (allotopes) originating from genetic variation within a species involving different alleles encoding the constant regions of heavy and kappa light chain loci (allotopes are not found on lambda light chains). Because of this polymorphism, IgG allotopes from any given individual are not present in all individuals, and patients receiving 'non-self' IgG (e.g. pooled IgG preparations or blood transfusions) may react with anti-allotypic responses. This is also the case, when patients are 'immunized' with recombinant constructs involving human IgG constant regions. C2: |
||